Gender Male
Investor Type
Philip Scheltens, M.D., Ph.D., head, EQT Life Sciences' LSP Dementia Fund.
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
obfuscated obfuscation | Aerska | LSP Dementia Fund | Series A - Aerska | obfuscated obfuscation | |
obfuscated obfuscation | Exciva | EQT Life Sciences | Series B - Exciva | obfuscated obfuscation | |
obfuscated obfuscation | ![]() Asceneuron | EQT Life Sciences | ![]() Series C - Asceneuron | obfuscated obfuscation | |
obfuscated obfuscation | QurAlis | EQT Life Sciences | Series B - QurAlis | obfuscated obfuscation | |
obfuscated obfuscation | Nobi | LSP Dementia Fund | Venture Round - Nobi | obfuscated obfuscation |
